A new study led by UC Davis MIND Institute researchers found a distinct DNA methylation signature in the cord blood of newborns who were eventually diagnosed with autism spectrum disorder (ASD). This signature mark spanned DNA regions and genes linked to early fetal neurodevelopment. The findings may hold clues for early diagnosis and intervention.

A massive problem like Alzheimer's disease --which affects nearly 50 million people worldwide--requires bold solutions. New funding expected to total $17.8 million, awarded to USC's Mark and Mary Stevens Neuroimaging Informatics Institute and its collaborators, is one key piece of that puzzle.

Old friends get together to relax, share meals, and trust and support each other. In the latter part of life, these friendships are highly valued. Recent research shows this happens in chimpanzees as well as humans.

In the analysis published in Indoor Air, the team looked at indoor air, thermal, acoustic, and lighting conditions. The collected evidence from 21 studies showed that the indoor environmental quality can contribute to the quality of learning.

Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at the Case Western Reserve University School of Medicine.

Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

The first widespread reports that SARS-CoV-2 might be affecting our nervous system were quite innocuous. But over the following months, reports of far more severe neurological side effects emerged. In this article, we take a look at the neurological symptoms of COVID-19.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

Clinical trials are a significant milestone in the development of innovative drugs and therapies for people diagnosed with different medical conditions including multiple sclerosis (MS). In this article, we examine how technology can make it easier for people to find and enroll on clinical trials.

As microscopes have improved, so too has their resolution and their ability to image cellular substructure, even down to the single-molecule level. Researchers can now investigate the carefully orchestrated trafficking and interaction of organelles, cargo, and biomolecules that sustain cellular life.

A profile piece exploring the life and career of the molecular biologist Professor Oded Rechavi.